P. Bellecave

C. Charpentier, S. Cauchemez, J. Pawlotsky, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference

R. Bartenschlager, H. Blum, D. Moradpour, 2009, Hepatology.

Selection of DNA aptamers that bind the RNA-dependent RNA polymerase of hepatitis C virus and inhibit viral RNA synthesis in vitro.

P. Bellecave, M. Andreola, L. Tarrago-Litvak, 2003, Oligonucleotides.

Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012–2014

F. Dabis, H. Fleury, E. Lazaro, 2015, Open forum infectious diseases.

Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Cellular uptake of ODNs in HIV-1 human-infected cells: a role for viral particles in DNA delivery?

P. Bellecave, M. Métifiot, M. Andreola, 2007, Oligonucleotides.

Template requirements and binding of hepatitis C virus NS5B polymerase during in vitro RNA synthesis from the 3′‐end of virus minus‐strand RNA

P. Bellecave, M. Ventura, S. Litvak, 2005, The FEBS journal.

Prevalence and Evolution of Low Frequency HIV Drug Resistance Mutations Detected by Ultra Deep Sequencing in Patients Experiencing First Line Antiretroviral Therapy Failure

B. Masquelier, D. Neau, P. Morlat, 2014, PloS one.

Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?

V. Calvez, C. Charpentier, C. Delaugerre, 2019, The Journal of antimicrobial chemotherapy.

Kinetics of HIV-1 CTL Epitopes Recognized by HLA I Alleles in HIV-Infected Individuals at Times near Primary Infection: The Provir/Latitude45 Study

M. Wainberg, J. Routy, H. Fleury, 2014, PLoS ONE.

High decay of blood HIV reservoir when tenofovir/emtricitabine/elvitegravir/cobicistat is initiated during the acute primary HIV infection

P. Morlat, P. Bellecave, F. Bonnet, 2017, The Journal of antimicrobial chemotherapy.

Determinants for Membrane Association of the Hepatitis C Virus NS2 Protease Domain

F. Penin, D. Moradpour, P. Bellecave, 2014, Journal of Virology.

Detection of low-frequency HIV type 1 reverse transcriptase drug resistance mutations by ultradeep sequencing in naive HIV type 1-infected individuals.

H. Fleury, P. Bellecave, S. Reigadas, 2014, AIDS research and human retroviruses.

A fresh look at interferon‐α signaling and treatment outcomes in chronic hepatitis C

D. Moradpour, P. Bellecave, 2008, Hepatology.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Karin J. Metzner, Huldrych F. Günthard, E. Nicastri, 2014, The Journal of antimicrobial chemotherapy.

A picture says more than a thousand words: Structural insights into hepatitis C virus translation initiation

D. Moradpour, P. Bellecave, 2006, Hepatology.

Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).

M. Ziol, V. Paradis, C. Delaugerre, 2020, Journal of hepatology.

Molecular Characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and Impact of T-Cell Epitope Mutations on HLA Recognition (ANRS 12159)

H. Fleury, E. Lazaro, P. Bellecave, 2011, PloS one.

Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.

K. Metzner, A. d’Arminio Monforte, A. Schultze, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

GCN2 phosphorylates HIV-1 integrase and decreases HIV-1 replication by limiting viral integration

A. Jaspart, C. Calmels, O. Cosnefroy, 2017, Scientific Reports.

High Prevalence of Antiretroviral Drug Resistance among HIV-1-Untreated Patients in Guinea-Conakry and in Niger

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2011, Antiviral therapy.

Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.

V. Calvez, C. Charpentier, P. Bellecave, 2021, The Journal of antimicrobial chemotherapy.

Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

V. Calvez, C. Charpentier, F. Brun-Vézinet, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients

A. d’Arminio Monforte, H. Günthard, E. Bernasconi, 2019, Open forum infectious diseases.

A Low Level of Darunavir Resistance–Associated Mutation Emergence in Patients With Virological Failure During Long-term Use of Darunavir in People With HIV. The ANRS CO3 Aquitaine Cohort

D. Neau, E. Lazaro, P. Bellecave, 2020, Open forum infectious diseases.

New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017

V. Calvez, P. Bellecave, D. Descamps, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Phylogenetic analysis of HIV-1 archived DNA in blood and gut-associated lymphoid tissue in patients receiving antiretroviral therapy: a study from Provir/Latitude45 project

M. Soares, J. Routy, H. Fleury, 2020, bioRxiv.

Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort

M. Ziol, C. Delaugerre, C. Katlama, 2020 .

Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA

H. Fleury, P. Bellecave, P. Recordon-Pinson, 2017, PloS one.

Tobacco, alcohol, cannabis, and illicit drug use and their association with CD4/CD8 cell count ratio in people with controlled HIV: a cross-sectional study (ANRS CO3 AQUIVIH-NA-QuAliV)

V. Gaborieau, D. Breilh, D. Neau, 2023, BMC Infectious Diseases.

sHIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies

J. Sterne, H. Günthard, C. Sabin, 2023, medRxiv : the preprint server for health sciences.

A Simple and Fast Method to Sequence the Full-Length Spike Gene for SARS-CoV-2 Variant Identification from Patient Samples

P. Bellecave, M. Métifiot, M. Andreola, 2021, COVID.